|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 47/60 | (2017.01) |
| A61K 47/60 | (2017.08) | ||
| A61K 47/64 | (2017.01) | ||
| A61P 27/02 | (2018.01) | ||
| A61P 27/02 | (2006.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61P 43/00 | (2006.01) | ||
| A61P 9/00 | (2018.01) | ||
| A61P 9/10 | (2006.01) | ||
| A61P 9/10 | (2018.01) | ||
| A61P 9/00 | (2006.01) | ||
| A61P 3/10 | (2018.01) | ||
| A61P 3/10 | (2006.01) | ||
| A61K 47/6903 | (2017.08) | ||
| A61K 47/69 | (2017.01) |
| (11) | Number of the document | 2906246 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13774165.8 |
| Date of filing the European patent application | 2013-10-08 | |
| (97) | Date of publication of the European application | 2015-08-19 |
| (45) | Date of publication and mention of the grant of the patent | 2023-07-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2013/070959 |
| Date | 2013-10-08 |
| (87) | Number | WO 2014/056923 |
| Date | 2014-04-17 |
| (30) | Number | Date | Country code |
| 12188226 | 2012-10-11 | EP |
| (72) |
RAU, Harald , DE
KNAPPE, Thomas , DE
LAUFER, Burkhardt , DE
REIMANN, Romy , DE
WEISBROD, Samuel , DE
SPROGĂE, Kennett , DK
BISEK, Nicola , DE
STARK, Sebastian , DE
VOIGT, Tobias , DE
|
| (73) |
Ascendis Pharma Ophthalmology Division A/S ,
Tuborg Boulevard 12, 2900 Hellerup,
DK
|
| (54) | VEGF NEUTRALIZING PRODRUGS COMPRISING RANIBIZUMAB FOR THE TREATMENT OF OCULAR CONDITIONS CHARACTERIZED BY OCULAR NEOVASCULARIZATION |
| VEGF NEUTRALIZING PRODRUGS COMPRISING RANIBIZUMAB FOR THE TREATMENT OF OCULAR CONDITIONS CHARACTERIZED BY OCULAR NEOVASCULARIZATION |